A Case Management Algorithm for Women Victims of Violence
NCT ID: NCT04953273
Last Updated: 2022-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
756 participants
INTERVENTIONAL
2021-07-06
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method: Prospective, multicenter, open-label, randomized controlled clinical trial, for women victims of violence. Victims randomized in VIGITRAUMA group will be contacted by phone at 3 weeks after the consultation in a clinical forensic medicine unit, and a second phone call can be done. If the subject is not contacted after the second phone call, he will receive a postcard.
Control group will benefit from usual follow-up.
All the subjects included will be then evaluated at 3 months, 6 months and 1 year during a phone call.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder
NCT06177223
Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
NCT03278171
Qualitative Study on the Perception of Changes in the Psychotherapy of Traumatized Young People
NCT06138522
The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women
NCT00183716
Empathy in Post-traumatic Stress Disorder in Comparaison to a Control Population
NCT05617781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vigitrauma
Contact by phone at 3 weeks after the consultation in a clinical forensic medicine unit, and a second phone call if necessary.
If the subject is not contacted after the second phone call, he will receive a postcard.
Vigitrauma
Case management algorithm using early phone contact
Control group
Usual follow-up.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vigitrauma
Case management algorithm using early phone contact
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years and older
* Consultation requested in a clinical forensic medicine unit after being victim of violence
* The person was exposed to: death, threatened death, actual or threatened serious injury, or actual or threatened sexual violence (PTSD criterion A - DSM -5)
* With social insurance
* Consent to participate to the study
Exclusion Criteria
* Intrafamilial or intimate partner violence
* Do not speak french
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, France
OTHER_GOV
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud Leroy, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital, Amiens
Amiens, , France
General Hospital, Boulogne sur Mer
Boulogne-sur-Mer, , France
University Hospital, Caen
Caen, , France
General Hospital, Creil
Creil, , France
University Hospital, Lille
Lille, , France
University Hospital, Rouen
Rouen, , France
General Hospital, Saint-Quentin
Saint-Quentin, , France
General Hospital, Valenciennes
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A02591-38
Identifier Type: OTHER
Identifier Source: secondary_id
2020_ 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.